|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171.48 USD | +4.26% |
|
-5.21% | -7.59% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.06B | 2.17B | 2.33B | 2.41B | 2.56B | |||||
Total Revenues | 2.06B | 2.17B | 2.33B | 2.41B | 2.56B | |||||
Cost of Goods Sold, Total | 220M | 250M | 292M | 269M | 294M | |||||
Gross Profit | 1.84B | 1.92B | 2.04B | 2.15B | 2.27B | |||||
Selling General & Admin Expenses, Total | 681M | 708M | 798M | 872M | 975M | |||||
R&D Expenses | 253M | 293M | 344M | 361M | 395M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 6.6M | 8.5M | 11.9M | 14M | 25M | |||||
Other Operating Expenses, Total | 941M | 1.01B | 1.15B | 1.25B | 1.39B | |||||
Operating Income | 904M | 908M | 884M | 899M | 876M | |||||
Interest Expense, Total | -2.2M | -4.6M | -1.8M | -2.3M | -1.8M | |||||
Interest And Investment Income | 78.2M | 66.1M | 67.6M | 92.4M | 93.6M | |||||
Net Interest Expenses | 76M | 61.5M | 65.8M | 90.1M | 91.8M | |||||
Currency Exchange Gains (Loss) | -4.5M | 200K | -3.3M | -3.8M | -2.1M | |||||
EBT, Excl. Unusual Items | 976M | 969M | 947M | 985M | 966M | |||||
Gain (Loss) On Sale Of Investments | -4.9M | -19.6M | -18.5M | -9.8M | 6.4M | |||||
EBT, Incl. Unusual Items | 971M | 950M | 928M | 976M | 972M | |||||
Income Tax Expense | 124M | 134M | 131M | 135M | 126M | |||||
Earnings From Continuing Operations | 847M | 816M | 797M | 840M | 846M | |||||
Net Income to Company | 847M | 816M | 797M | 840M | 846M | |||||
Net Income - (IS) | 847M | 816M | 797M | 840M | 846M | |||||
Net Income to Common Incl Extra Items | 847M | 816M | 797M | 840M | 846M | |||||
Net Income to Common Excl. Extra Items | 847M | 816M | 797M | 840M | 846M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.03 | 6.13 | 6.36 | 7.19 | 7.65 | |||||
Basic EPS - Continuing Operations | 6.03 | 6.13 | 6.36 | 7.19 | 7.65 | |||||
Basic Weighted Average Shares Outstanding | 140M | 133M | 125M | 117M | 111M | |||||
Net EPS - Diluted | 5.96 | 6.08 | 6.31 | 7.1 | 7.46 | |||||
Diluted EPS - Continuing Operations | 5.96 | 6.08 | 6.31 | 7.1 | 7.46 | |||||
Diluted Weighted Average Shares Outstanding | 142M | 134M | 126M | 118M | 113M | |||||
Normalized Basic EPS | 4.34 | 4.55 | 4.73 | 5.27 | 5.46 | |||||
Normalized Diluted EPS | 4.29 | 4.52 | 4.68 | 5.2 | 5.32 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 925M | 930M | 909M | 932M | 935M | |||||
EBITA | 906M | 909M | 886M | 909M | 911M | |||||
EBIT | 904M | 908M | 884M | 899M | 876M | |||||
EBITDAR | 938M | 938M | 915M | 940M | 944M | |||||
Total Revenues (As Reported) | 2.06B | 2.17B | 2.33B | 2.41B | 2.56B | |||||
Effective Tax Rate - (Ratio) | 12.79 | 14.11 | 14.15 | 13.87 | 13 | |||||
Current Domestic Taxes | 112M | 131M | 118M | 141M | 120M | |||||
Current Foreign Taxes | 1.7M | 7.1M | 12.7M | 13.1M | 16.4M | |||||
Total Current Taxes | 114M | 138M | 130M | 154M | 137M | |||||
Deferred Domestic Taxes | 800K | -1.1M | -1.3M | -23M | -5.9M | |||||
Deferred Foreign Taxes | 9.7M | -2.9M | 2.3M | 4.6M | -4.6M | |||||
Total Deferred Taxes | 10.5M | -4M | 1M | -18.4M | -10.5M | |||||
Normalized Net Income | 610M | 606M | 592M | 616M | 604M | |||||
Interest on Long-Term Debt | 2.2M | 4.6M | 1.8M | 2.3M | 1.8M | |||||
Non-Cash Pension Expense | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 3.7M | 4.1M | 4.6M | 7.6M | 12.5M | |||||
Selling and Marketing Expenses | 570M | 598M | 675M | 747M | 863M | |||||
General and Administrative Expenses | 112M | 111M | 116M | 117M | 112M | |||||
Research And Development Expense From Footnotes | 259M | 301M | 362M | 383M | 420M | |||||
Net Rental Expense, Total | 13.1M | 8.1M | 6.3M | 7.7M | 9.6M | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | 4.95M | |||||
Imputed Operating Lease Depreciation | - | - | - | - | 4.65M | |||||
Stock-Based Comp., COGS (Total) | 4.5M | 4.8M | 5.4M | 7.7M | 8.6M | |||||
Stock-Based Comp., R&D Exp. (Total) | 23.5M | 31.8M | 42M | 48.7M | 53.1M | |||||
Stock-Based Comp., S&M Exp. (Total) | 36.8M | 42.8M | 43.2M | 56.3M | 58.2M | |||||
Stock-Based Comp., G&A Exp. (Total) | 47.7M | 40.9M | 40.8M | 32.6M | 29.8M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 112M | 120M | 131M | 145M | 150M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















